Steven B. Wong

Array ( [id] => 7163445 [patent_doc_number] => 20050085493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Quinazolinone derivatives and their use as cb agonists' [patent_app_type] => utility [patent_app_number] => 10/503779 [patent_app_country] => US [patent_app_date] => 2003-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15285 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085493.pdf [firstpage_image] =>[orig_patent_app_number] => 10503779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362098 [patent_doc_number] => 20040014747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'CRF receptor antagonists and methods relating thereto' [patent_app_type] => new [patent_app_number] => 10/357315 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6883 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014747.pdf [firstpage_image] =>[orig_patent_app_number] => 10357315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 953928 [patent_doc_number] => 06958342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-25 [patent_title] => 'Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto' [patent_app_type] => utility [patent_app_number] => 10/354904 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 11805 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/958/06958342.pdf [firstpage_image] =>[orig_patent_app_number] => 10354904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 428795 [patent_doc_number] => 07268230 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-11 [patent_title] => 'Quinazoline compounds' [patent_app_type] => utility [patent_app_number] => 10/502538 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63279 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/268/07268230.pdf [firstpage_image] =>[orig_patent_app_number] => 10502538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 460092 [patent_doc_number] => 07241767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-10 [patent_title] => 'Quinazoline(di)ones for invertebrate pest control' [patent_app_type] => utility [patent_app_number] => 10/496724 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36030 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/241/07241767.pdf [firstpage_image] =>[orig_patent_app_number] => 10496724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797577 [patent_doc_number] => 20030176451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Heterocyclic compounds' [patent_app_type] => new [patent_app_number] => 10/342810 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36462 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176451.pdf [firstpage_image] =>[orig_patent_app_number] => 10342810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697322 [patent_doc_number] => 20030109516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 10/340287 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21333 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109516.pdf [firstpage_image] =>[orig_patent_app_number] => 10340287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040597 [patent_doc_number] => 20050159431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Substituted alkyl uracils and thereof' [patent_app_type] => utility [patent_app_number] => 10/501033 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9877 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159431.pdf [firstpage_image] =>[orig_patent_app_number] => 10501033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6669487 [patent_doc_number] => 20030114471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer' [patent_app_type] => new [patent_app_number] => 10/312301 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3865 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20030114471.pdf [firstpage_image] =>[orig_patent_app_number] => 10312301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826919 [patent_doc_number] => 07402585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-22 [patent_title] => 'Substituted quinazoline derivatives as inhibitors of aurora kinases' [patent_app_type] => utility [patent_app_number] => 10/499684 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64594 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402585.pdf [firstpage_image] =>[orig_patent_app_number] => 10499684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207065 [patent_doc_number] => 20050043333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Quinazolinone derivative' [patent_app_type] => utility [patent_app_number] => 10/499348 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7014 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043333.pdf [firstpage_image] =>[orig_patent_app_number] => 10499348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020162 [patent_doc_number] => 20050222181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'COMPOUNDS IN THE TREATMENT OF DEMENTIA RELATED DISEASES, ALZHEIMER\'S DISEASE AND CONDITIONS ASSOCIATED WITH GLYCOGEN SYNTHASE KINASE-3' [patent_app_type] => utility [patent_app_number] => 10/499388 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8368 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222181.pdf [firstpage_image] =>[orig_patent_app_number] => 10499388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711637 [patent_doc_number] => 20030171386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Small molecules for the treatment of abnormal cell growth \n' [patent_app_type] => new [patent_app_number] => 10/315863 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15349 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171386.pdf [firstpage_image] =>[orig_patent_app_number] => 10315863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852303 [patent_doc_number] => 20030144506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth' [patent_app_type] => new [patent_app_number] => 10/307603 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23762 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144506.pdf [firstpage_image] =>[orig_patent_app_number] => 10307603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026836 [patent_doc_number] => 20050020612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => '4-Aryliquinazolines and the use thereof as nhe-3 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/499972 [patent_app_country] => US [patent_app_date] => 2002-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10892 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020612.pdf [firstpage_image] =>[orig_patent_app_number] => 10499972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939833 [patent_doc_number] => 20050113396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => '2-Guanidino-4-heterocyclylquinazolines' [patent_app_type] => utility [patent_app_number] => 10/498806 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9180 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113396.pdf [firstpage_image] =>[orig_patent_app_number] => 10498806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122944 [patent_doc_number] => 20050014773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Therapeutic use' [patent_app_type] => utility [patent_app_number] => 10/496464 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49697 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014773.pdf [firstpage_image] =>[orig_patent_app_number] => 10496464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 554986 [patent_doc_number] => 07160891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-09 [patent_title] => 'Quinazoline derivatives for the treatment of T cell mediated diseases' [patent_app_type] => utility [patent_app_number] => 10/496587 [patent_app_country] => US [patent_app_date] => 2002-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82526 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/160/07160891.pdf [firstpage_image] =>[orig_patent_app_number] => 10496587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 716457 [patent_doc_number] => 07053216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'Modulators of Rho C activity' [patent_app_type] => utility [patent_app_number] => 10/300651 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6872 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053216.pdf [firstpage_image] =>[orig_patent_app_number] => 10300651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706829 [patent_doc_number] => 20030153563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'CRF receptor antagonists and methods relating thereto' [patent_app_type] => new [patent_app_number] => 10/294490 [patent_app_country] => US [patent_app_date] => 2002-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9217 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153563.pdf [firstpage_image] =>[orig_patent_app_number] => 10294490 [rel_patent_id] =>[rel_patent_doc_number] =>)